Lautenschlager I - Search Results

1

Cellular and molecular mechanisms in allograft arteriosclerosis.

Häyry P, Mennander A, Yilmaz S, Ustinov J, Räisänen A, Lautenschlager I, Lemström K, Bruggeman CA, Paavonen T. Häyry P, et al. Among authors: lautenschlager i. Transplant Proc. 1992 Dec;24(6):2359-61. Transplant Proc. 1992. PMID: 1334582 Review. No abstract available.

2

Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat.

Lemström KB, Bruning JH, Bruggeman CA, Koskinen PK, Aho PT, Yilmaz S, Lautenschlager IT, Häyry PJ. Lemström KB, et al. Among authors: lautenschlager it. Circulation. 1994 Oct;90(4):1969-78. doi: 10.1161/01.cir.90.4.1969. Circulation. 1994. PMID: 7923687

3

Direct induction of class II molecules by cytomegalovirus in rat heart microvascular endothelial cells is inhibited by ganciclovir (DHPG).

Ustinov JA, Lahtinen TT, Bruggeman CA, Häyry PJ, Lautenschlager IT. Ustinov JA, et al. Among authors: lautenschlager it. Transplantation. 1994 Nov 15;58(9):1027-31. doi: 10.1097/00007890-199411150-00009. Transplantation. 1994. PMID: 7974730

4

Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.

Lemström KB, Bruning JH, Bruggeman CA, Lautenschlager IT, Häyry PJ. Lemström KB, et al. Among authors: lautenschlager it. Am J Pathol. 1994 Jun;144(6):1334-47. Am J Pathol. 1994. PMID: 8203471 Free PMC article.

5

Cytomegalovirus infection accelerates cardiac allograft vasculopathy: correlation between angiographic and endomyocardial biopsy findings in heart transplant patients.

Koskinen PK, Nieminen MS, Krogerus LA, Lemström KB, Mattila SP, Häyry PJ, Lautenschlager IT. Koskinen PK, et al. Among authors: lautenschlager it. Transpl Int. 1993;6(6):341-7. doi: 10.1007/BF00335972. Transpl Int. 1993. PMID: 8297464

6

Effect of ganciclovir prophylaxis on cytomegalovirus-enhanced allograft arteriosclerosis.

Lemström KB, Koskinen PK, Bruning JH, Bruggeman CA, Lautenschlager IT, Häyry PJ. Lemström KB, et al. Among authors: lautenschlager it. Transpl Int. 1994;7 Suppl 1:S383-4. doi: 10.1111/j.1432-2277.1994.tb01398.x. Transpl Int. 1994. PMID: 11271259

7

Does CMV infection affect the outcome of renal allografts?

Lautenschlager I, Salmela K, Häyry P. Lautenschlager I, et al. Transplant Proc. 1992 Feb;24(1):281-2. Transplant Proc. 1992. PMID: 1311471 No abstract available.

8

Anti-CMV hyperimmune globulin prophylaxis does not prevent CMV disease in CMV-negative renal transplant patients.

Pakkala S, Salmela K, Lautenschlager I, Ahonen J, Häyry P. Pakkala S, et al. Among authors: lautenschlager i. Transplant Proc. 1992 Feb;24(1):283-4. Transplant Proc. 1992. PMID: 1311472 No abstract available.

9

CMV infection in various cell types of human kidney.

Ustinov J, Mattila P, Häyry P, Lautenschlager I. Ustinov J, et al. Among authors: lautenschlager i. Transplant Proc. 1992 Feb;24(1):285. Transplant Proc. 1992. PMID: 1311473 No abstract available.

10

Endothelialitis in accelerated allograft arteriosclerosis in human cardiac transplant recipients.

Paavonen T, Mennander A, Lautenschlager I, Häyry P. Paavonen T, et al. Among authors: lautenschlager i. Transplant Proc. 1992 Feb;24(1):342-3. Transplant Proc. 1992. PMID: 1539307 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters